A Randomized, Open-label, Single Dose, Dose-rising 10-sequence, 3-period Balanced Incomplete Blocked Clinical Trial to Evaluate Dose-proportionality of Dilatrend SR in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Carvedilol (Primary)
- Indications Angina pectoris; Heart failure; Hypertension
- Focus Pharmacokinetics
- 13 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register; KCT0000133).
- 23 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.